Brief: Tiziana Life Sciences Announces Updated Clinical And Pet Scan Findings For Intranasal Foralumab
08/01/2024 13:33
Jan 8 (Reuters) - Tiziana Life Sciences Ltd TLSA.O :
* TIZIANA LIFE SCIENCES ANNOUNCES UPDATED CLINICAL AND PET
SCAN
FINDINGS FOR INTRANASAL FORALUMAB IN TWO NEW MULTIPLE SCLEROSIS
PATIENTS
Source text for Eikon: ID:nGNX2t1GjJ
Further company coverage: TLSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tiziana Life Sciences
See all newsBrief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis
U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight
Tiziana Life Sciences rises as nasal MS drug shows promise in early study